Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?

To: Stephen How who wrote (931)	5/11/1998 11:51:00 PM
From: Jim Roof	Read Replies (1) \| Respond to of 1432

Biotime grew out of research related to cryomedical issues. Hextend, as I understand it, was originally developed as a hypothermic blood agent that would overcome the messy and lethal clotting of blood that happens at extremely low temperatures (from a biological perspective). There is an article somewhere about a baboon that was put in a state of cryogenic 'freeze' using a Hextend related formula. After a number of hours the animal was revived to normal health. As an interesting aside, it has been concluded from research that a brain which has been biologically 'frozen' retains its memory. This might seem obvious but there was the chance that the brain's memory is constantly being refreshed like the RAS and CAS charge cycles in your computer's RAM. Anyway, Hextend has a few other close cousins at BTIM. One is for low temperature surgery and there may be a specific formulation for organ storage. I am not sure on the latter point though. Jim